Arthur M. Krieg, Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. (CMPI), bought 66,440 shares at $11.40 ($741K) on 2021-03-29, disclosed to the SEC on 2021-03-31.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.94 | 17,468 | $191K | 25.8% |
| 2 | $10.94 | 17,468 | $191K | 25.8% |
| 3 | $11.40 | 15,752 | $180K | 24.2% |
| 4 | $11.40 | 15,752 | $180K | 24.2% |
| Total | $11.16 avg | 66,440 | $741K | 100% |
| Filing → |
| CMPI | BUY | 2021-05-19 | $349K | — | Filing → |
| CMPI | BUY | 2021-03-29 | $290K | — | Filing → |
| CMPI | BUY | 2021-01-28 | $22K | — | Filing → |